These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 24038038)
1. Quality indicators for ductal carcinoma in situ (DCIS) of the breast: development using a multidisciplinary delphi process and its use in monitoring population-based treatment. Chin-Lenn L; Craighead P; Bryant HE; Mack L; Temple W; Ghali W; Quan ML J Surg Oncol; 2013 Nov; 108(6):348-51. PubMed ID: 24038038 [TBL] [Abstract][Full Text] [Related]
2. Optimal management of ductal carcinoma in situ of the breast. Sakorafas GH; Farley DR Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563 [TBL] [Abstract][Full Text] [Related]
3. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands. van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376 [TBL] [Abstract][Full Text] [Related]
4. Is sentinel node biopsy necessary in conservatively treated DCIS? Julian TB; Land SR; Fourchotte V; Haile SR; Fisher ER; Mamounas EP; Costantino JP; Wolmark N Ann Surg Oncol; 2007 Aug; 14(8):2202-8. PubMed ID: 17534687 [TBL] [Abstract][Full Text] [Related]
5. Ductal carcinoma in situ: value of sentinel lymph node biopsy. Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457 [TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Sakorafas GH; Tsiotou AG Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968 [TBL] [Abstract][Full Text] [Related]
7. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999. Wu X; Chen VW; Ruiz B; Andrews PA; Hsieh MC; Schmidt BA; Correa CN; Fontham ET J La State Med Soc; 2003; 155(4):206-13. PubMed ID: 14506828 [TBL] [Abstract][Full Text] [Related]
8. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. Worni M; Akushevich I; Greenup R; Sarma D; Ryser MD; Myers ER; Hwang ES J Natl Cancer Inst; 2015 Dec; 107(12):djv263. PubMed ID: 26424776 [TBL] [Abstract][Full Text] [Related]
9. The management of ductal carcinoma in situ of the breast: a screened population-based analysis. Rakovitch E; Pignol JP; Chartier C; Hanna W; Kahn H; Wong J; Mai V; Paszat L Breast Cancer Res Treat; 2007 Mar; 101(3):335-47. PubMed ID: 16838110 [TBL] [Abstract][Full Text] [Related]
10. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952 [TBL] [Abstract][Full Text] [Related]
12. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? Mabry H; Giuliano AE; Silverstein MJ Am J Surg; 2006 Oct; 192(4):455-7. PubMed ID: 16978948 [TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ. Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441 [TBL] [Abstract][Full Text] [Related]
14. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand. Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824 [TBL] [Abstract][Full Text] [Related]
15. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953 [TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy for localised ductal carcinoma in situ? Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871 [TBL] [Abstract][Full Text] [Related]
17. Trends in the treatment of ductal carcinoma in situ of the breast. Baxter NN; Virnig BA; Durham SB; Tuttle TM J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469 [TBL] [Abstract][Full Text] [Related]
18. Ductal carcinoma in situ, complexities and challenges. Leonard GD; Swain SM J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110 [TBL] [Abstract][Full Text] [Related]
19. The impact of publication of Australian treatment recommendations for DCIS on clinical practice: A population-based, "before-after" study. White V; Pruden M; Kitchen P; Villanueva E; Erbas B Eur J Surg Oncol; 2010 Oct; 36(10):949-56. PubMed ID: 20724103 [TBL] [Abstract][Full Text] [Related]
20. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. Park HS; Park S; Cho J; Park JM; Kim SI; Park BW J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]